All In MedTech

Device Trial Radar · NCT03321344

Safety and Initial Feasibility of Using the Neurolyser for Facet Related Low Back Pain

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Facet Related Low Back Pain

Last checked: Nov 19, 2026Latest source record: Jan 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Dec 5, 2017

Primary completion

Feb 28, 2019

Study completion Feb 19, 2020

Sponsor

Lead sponsor
FUSMobile Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Focused Ultrasound Foundation
First posted
Oct 25, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s

Conditions

  • Facet Related Low Back Pain

Interventions

  • Focused Ultrasound Thermal ablationDevice

    Focused Ultrasound Thermal ablation of the Medial Nerve Branch

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. NRSTime frame: Base line, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure
  2. RMDTime frame: Base line, 1 & 4 weeks, 3, 6 & 12 months after procedure
  3. SafteyTime frame: Base line, Procedure day, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Alan Edwards Pain Management Unit - Montreal General Hospital

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.